Colgate-Palmolive stock
Price history
+27.38% over the period1 year: from $78.81 (November 17, 2025) to $100.39 (November 17, 2026), +27.38%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | $100.39 |
| October 30, 2026 | $95.29 |
| September 30, 2026 | $85.32 |
| August 31, 2026 | $89.82 |
| July 31, 2026 | $91.30 |
| June 30, 2026 | $91.68 |
| May 29, 2026 | $90.13 |
| April 30, 2026 | $85.36 |
| March 31, 2026 | $85.23 |
| February 27, 2026 | $99.14 |
| January 30, 2026 | $90.29 |
| December 31, 2025 | $79.02 |
| November 28, 2025 | $80.39 |
| November 17, 2025 | $78.81 |
At a glance
The company
Manufactures and sells consumer products including oral care, personal care, home care and pet nutrition under multiple brands globally
Latest results
Quarter to September 30, 2026 · EPS $0.97 (estimate $0.93)
Next event
TickerLandia's take on Colgate-Palmolive
- Pricier than usual relative to earnings: P/E on the latest fiscal year 38 vs a median of 28 over its last 10 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 39 vs 22 (+79%) in a group of 11.
- Strong point: Profitability (75/100 in its group). Weak point: Financial strength (31/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−2.16% from the 52-week high
Analysts · 21 analysts
Average target$101.70+2.10% vs. price
Buy 13 · Hold 7 · Sell 1 · Buy
TickerLandia Fingerprint: Colgate-Palmolive
Compared with similar companies: very low risk and very high price.
Financials and price compared with 27 companies in the household & personal products industry, worldwide. Momentum and risk compared with 883 North American stocks.
Pricevery high82
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 39.3 87 EV/EBITDA 17.0 76 Forward P/E 24.6 75 Price/book 279.0 98 Price/sales 3.77 72 Profitabilityhigh75
How much it earns on revenue and capital.
Metric Value Position in group ROE 231.7% 94 ROA 16.0% 91 Operating margin 20.7% 76 Gross margin 60.6% 72 Net margin 9.6% 43 Earnings stabilityaverage43
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 2.4% 28 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 57 Growthhigh62
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +4.29% 69 Revenue growth (year over year) +4.60% 65 Earnings growth (year over year) +3.30% 54 Financial strengthlow31
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 1.49 31 Interest coverage 15.9 57 Current ratio 0.96 28 Debt/equitycounts in reverse: lower means more financial strength 12.1 6 Dividendhigh69
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 37 years 91 Payout ratio 82.1% 70 Dividend yield 2.1% 46 Market momentumstrong74
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +13.09% 81 Relative strength (6 months) +12.27% 68 1-year return +29.39% 74 Distance from 200-day average +11.76% 75 Riskvery low16
How much the price swings.
Metric Value Position in group Beta (1 year) −0.09 11 Volatility (60 days) 22.6% 18 Maximum drawdown (12 months) 17.5% 18
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 17, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Colgate-Palmolive is pricier than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Colgate-Palmolive's P/E today is 38.2, above the median of its last 10 fiscal years (28.0; between 21.6 and 37.0 from 2016 to 2025). Colgate-Palmolive's P/E (trailing 12 months): 39.3, +79% against the median of a group of 11 similar companies (21.9).
Compared with 11 similar companies
| Metric | Colgate-Palmolive | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 39.3 | High | |
| Forward P/E | 24.6 | Middle | |
| Operating margin | 20.7% | Middle | |
| ROE | 231.7% | High | |
| Debt/equity | 12.1 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Colgate-Palmolive. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$5.37B
Latest quarter · Q3 2026
Net income
$751M
Latest quarter · Q3 2026
Quarterly net margin
14.0%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $80.28B
- P/E
- 39.3
- EPS
- $2.57
- Volume
- 8.73M
- Daily trading
- €463.72M
- Dividend yield
- 2.12%
- Last ex-dividend on October 20, 2026
How Colgate-Palmolive is changing
All resultsRevenue grew 4.4% a year on average over the last 5 years
Profits turn into cash: free cash flow equal to 140% of net income
Shares outstanding down 5.6% in 5 years
Returns
Colgate-Palmolive returns with dividends
$1,000 invested in Colgate-Palmolive 5 years ago, on November 17, 2021, would be worth $1,456 today with dividends reinvested: +45.65% in total, +7.81% per year. On price alone it would be $1,294 (+29.40%).
| Period | Colgate-Palmolive | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +7.49% | −3.17% | $1,075 |
| 6 months | +13.03% | +0.11% | $1,130 |
| Year to date | +27.04% | +8.34% | $1,270 |
| 1 year | +30.44% | +11.15% | $1,304 |
| 3 years | +42.32% | +64.30% | $1,423 |
| 5 years | +45.65% | +58.18% | $1,456 |
| 10 years | +92.61% | +239.10% | $1,926 |
Over the last 6 months it has done better than 62% of the stocks in the Consumer sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Colgate-Palmolive: technical analysis
Colgate-Palmolive is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 8.4% below its highest close since January 2, 1990 ($108.77, September 4, 2024).
- Trend
- Upward
- RSI (14 sessions)
- 62
- Between 30 and 70
- vs 200-session average
- +10.18%
Active signals
Golden cross: the 50-session average has crossed above the 200-session average.
since November 4, 2026
Support and resistance
Price areas where Colgate-Palmolive has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price$99.61
- Support$97.81−1.80%2 touches, last on October 22, 2026
- Support$95.80−3.82%3 touches, last on July 28, 2026
- Support$92.98−6.66%4 touches, last on June 24, 2026
Volatility and risk
Over the last year it has often moved in the opposite direction to the S&P 500.
- Beta (1 year) vs S&P 500
- −0.10
- Volatility (60 sessions, annualised)
- 22.6%
- Largest fall in the last year
- −17.48%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Colgate-Palmolive: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Colgate-Palmolive has been October: +3.05% on average, positive in 24 years out of 37. The weakest has been January: −0.98% on average, positive in 13 years out of 36. November, the current month, has been positive in 24 years out of 36 (+1.50% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.98% | −1.71% | 13 of 36 |
| February | +1.83% | +2.58% | 22 of 37 |
| March | +1.71% | +2.80% | 25 of 37 |
| April | +1.03% | +1.30% | 26 of 37 |
| May | +1.54% | +1.41% | 22 of 37 |
| June | +0.39% | −0.12% | 18 of 37 |
| July | +0.02% | +0.28% | 21 of 37 |
| August | −0.59% | +0.26% | 19 of 37 |
| September | −0.65% | +0.55% | 19 of 37 |
| October | +3.05% | +2.26% | 24 of 37 |
| November | +1.50% | +1.68% | 24 of 36 |
| December | +2.36% | +1.08% | 22 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Colgate-Palmolive and its competitors
Colgate-Palmolive sells its consumer products to households, dental and skin health professionals, pet specialty retailers and veterinarians, with traditional and eCommerce retailers, wholesalers and distributors in the United States and across many international markets.
- Headquarters
- New York, United States
- Employees
- 33,600
- Founded
- 1806
- Chief executive
- Noel Wallace
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Colgate-PalmoliveCL | $80.28B | 20.7% | 39.3 | +13.03% |
| Kimberly-ClarkKMB | $68.33B | 17.3% | 21.2 | +12.76% |
| Estée Lauder CompaniesEL | $39.35B | 11.9% | 108.6 | +30.19% |
| KenvueKVUE | $37.11B | 19.2% | 21.9 | +10.15% |
| Church And DwightCHD | $27.08B | 18.6% | 35.2 | +19.60% |
| Procter & GamblePG | $399.93B | 24.9% | 26.0 | +21.30% |
Same industry or related industries, similar size. Compare Colgate-Palmolive with its competitors · Full profile
